BlueFuse Multi Software

BlueFuse Multi Software

BlueFuse software provides molecular cytogenetic and in vitro fertilization (IVF) data analysis in a single framework. It offers a clear, intuitive user interface; a common workflow; and scales for the needs of your lab. This widely implemented software is used in over 150 clinical research laboratories globally and for more than 80 percent of the PGS cycles currently being screened.

BlueFuse helps labs efficiently and confidently:

  • Run many tests per day with minimal hands-on time
  • Securely store and retrieve sample information and associated reports
  • Create workflow and audit trails to meet lab and local requirements
  • Analyze array-based molecular cytogenetic and IVF data
  • Analyze NGS (next-generation sequencing)-based IVF data
BlueFuse Multi Software Demo

Innovative BlueFuse Multi Software provides molecular cytogenetic and in vitro fertilization (IVF) data analysis in a single framework. The seamless, scalable software solution helps simplify embryo screening and streamline the clinician’s workflow.

Watch Video

Screening embryos for aneuploidy prior to transfer has been shown to deliver significant improvements in IVF success (PGS)1. Preimplantation genetic diagnosis (PGD) enables screening of embryos for specific genetic conditions before transfer in an IVF procedure. BlueFuse Multi Software supplies laboratories with a single software solution for PGS and PGD.

Recent advances in microarray screening technologies have enabled identification of chromosomal microdeletions and microduplications (copy number variation). BlueFuse Multi software is sophisticated multi-user software for analyzing, visualizing, and interpreting results from molecular cytogenetics studies. With a clear, intuitive user interface, BlueFuse Multi generates accurate, user-independent results, quickly and efficiently.

Interested in receiving newsletters, case studies, and information on new applications? Enter your email address.

BlueFuse is available to all users of Illumina cytogenetic and PGS/PGD products with unlimited licenses per site. It is not available as an open platform to other vendors of cytogenetics or PGS/PGD products.

References
  1. Scott RT Jr, Ferry K, Su J, Tao X, Scott K, et al. (2012) Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study. Fertil Steril 97(4): 870–875.